Press Releases
2011, September 6: Skyline Diagnostics and Clavis Pharma to collaborate on patient selection biomarker discovery for leukemia drug elacytarabine
Collaboration with Clavis Pharma
2011, March 16: Dutch firm launches world’s first diagnostic chip that combines DNA technologies to rapidly classify AML patients
2011, March 9: Skyline Diagnostics Receives Dutch Innovation Support for Regulatory Approval of Novel Leukemia Diagnostic in the USA
Innovatiekrediet (pdf)
2010, Nov 15: Skyline Diagnostics, Erasmus MC and Sanquin Receive a Mibiton Share Facility Grant for International Study to Develop Acute Myeloid Leukemia Diagnostic Device
Mibiton grant (pdf)
2010 June 30: Skyline Diagnostics closes licensing agreement with Trovagene to use NPM1 mutation detection in novel technology for Acute Myeloid Leukemia diagnosis
NPM1 license from Trovagene (pdf)
-
-
News
-
25/11/2011 - by T Dijkmans | Posted in: Events
A 7-hill Skyline
Last Sunday afternoon, Skyline Diagnostics took part in the ‘Zevenheuvelenloop’ run in Nijmegen, The Netherlands.
Read more -
13/10/2011 - by T. Dijkmans | Posted in: Events
Skyline attends the ESH-EHA Workshop
The ESH-EHA Scientific Workshop AML "Molecular" will be held from October 14 to 16 in Mandelieu La Napoule, France.
Read more -
30/09/2011 - by Thomas Dijkmans | Posted in: Events
Skyline participates in CTMM Annual meeting 2011
At the CTMM Annual Meeting, which took place on 29 September 2011 at the Jaarbeurs in Utrecht, over 400 people...
Read more
-
Dr. Molewaterplein 50, Suite Ee1971, 3015 GE Rotterdam. The Netherlands, Europe. Phone: +31 (0)10 7038410. Fax: +31 (0)10 7043076. E-mail: info@skyline-diagnostics.com
